Jeffrey T L Smith - EVP & Chief Medical Officer at Zymeworks Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP & Chief Medical Officer
Issuer Symbol
ZYME on Nasdaq
All Insider Reports
All Insider Reports

Jeffrey T L Smith - trading volume in the past year for Zymeworks Inc.

Holdings reported by Jeffrey T L Smith for Zymeworks Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 35,334 $790,977 $14.92 12 Jan 2026 Direct Common Stock
Common Stock 26,708 $605,563 $22.67 12 Jan 2026 Direct

Transactions reported by Jeffrey T L Smith for Zymeworks Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.